title: Managing vaccines: defining the remit of primary care and specialist HIV clinics in the delivery of immunization to individuals with HIV infection.
abstract: The British HIV Association (BHIVA) has published guidelines for immunization of HIV-infected adults. A chart review of 200 HIV-infected patients diagnosed was conducted to determine shortcomings in previous practice and determine which vaccines should routinely be given in specialist HIV clinics and which might be able to be delegated to primary care clinics. Data were collected on administration of three categories of vaccinations: (1) vaccines used in all individuals with chronic disease (pneumococcal, influenza, swine flu H1N1); (2) targeted vaccinations used in non-immune individuals with HIV who are at risk of exposure (hepatitis A and hepatitis B); (3) routine vaccines traditionally delivered to the whole population (measles/mumps/rubella [MMR], diphtheria/tetanus/pertussis and meningitis C/ACWY). Pneumococcal vaccine was delivered to 54% of eligible patients, 52% of eligible individuals completed a full hepatitis B programme of vaccination and 21% (42/200) were naturally immune; hepatitis A vaccine was delivered to 36% of eligible individuals. With increasing demands on resources, it seems likely that HIV services will have to harness resources of primary care in vaccine programmes in relation to routine vaccines. By improving communication between primary and secondary care mistakes with live vaccination decisions could be avoided; HIV services should continue to perform targeted and chronic disease vaccines, i.e. for category 1 and category 2 vaccines.
authors.affiliation: Department of Genito-Urinary and HIV Medicine, Royal Victoria Hospital Belfast, Belfast, UK. quinnkj@doctors.org.uk
authors.forename: K J
authors.initials: KJ
authors.lastname: Quinn
authors.forename: E J
authors.initials: EJ
authors.lastname: McCarty
authors.forename: S P
authors.initials: SP
authors.lastname: Quah
authors.forename: C R
authors.initials: CR
authors.lastname: Emerson
authors.forename: C M
authors.initials: CM
authors.lastname: Donnelly
mesh_terms: D000328:Adult; D005260:Female; D015658:HIV Infections / Q000276:immunology* / Q000628:therapy*; D006506:Hepatitis A / Q000276:immunology / Q000517:prevention & control; D006509:Hepatitis B / Q000276:immunology / Q000517:prevention & control; D006801:Humans; D007114:Immunization / Q000379:methods*; D053118:Influenza A Virus, H1N1 Subtype / Q000276:immunology; D007251:Influenza, Human / Q000276:immunology / Q000517:prevention & control; D008297:Male; D008875:Middle Aged; D011320:Primary Health Care; D012189:Retrospective Studies; D014765:Viral Vaccines / Q000008:administration & dosage* / Q000276:immunology*
chemical_list: D014765:Viral Vaccines